Cargando…
An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids
Background: Associations of both common and rare genetic variants with fasting blood lipids have been extensively studied. However, most of the rare coding variants associated with lipids are population-specific, and exploration of genetic data from diverse population samples may enhance the identif...
Autores principales: | Geng, Xin, Irvin, Marguerite R., Hidalgo, Bertha, Aslibekyan, Stella, Srinivasasainagendra, Vinodh, An, Ping, Frazier-Wood, Alexis C., Tiwari, Hemant K., Dave, Tushar, Ryan, Kathleen, Ordovas, Jose M., Straka, Robert J., Feitosa, Mary F., Hopkins, Paul N., Borecki, Ingrid, Province, Michael A., Mitchell, Braxton D., Arnett, Donna K., Zhi, Degui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399202/ https://www.ncbi.nlm.nih.gov/pubmed/30863429 http://dx.doi.org/10.3389/fgene.2019.00158 |
Ejemplares similares
-
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study
por: Irvin, Marguerite R., et al.
Publicado: (2018) -
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015) -
Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Irvin, Marguerite R., et al.
Publicado: (2014) -
Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Das, Mithun, et al.
Publicado: (2016) -
The PPAR Alpha gene is associated with triglyceride, low-density cholesterol, and inflammation marker response to fenofibrate intervention: The GOLDN Study
por: Frazier-Wood, A.C., et al.
Publicado: (2012)